Breaking News Instant updates and real-time market news.

PFE

Pfizer

$43.43

0.43 (1.00%)

16:19
06/27/19
06/27
16:19
06/27/19
16:19

Pfizer names Scott Gottlieb to board of directors

Pfizer Inc. announced the election of Dr. Scott Gottlieb to its Board of Directors, effective immediately. Dr. Gottlieb was also appointed to the Regulatory and Compliance Committee and the Science and Technology Committee of Pfizer's Board. Dr. Gottlieb, a physician and medical policy expert, is currently a Special Partner of New Enterprise Associations, Inc.'s healthcare investment team and a Resident Fellow of the American Enterprise Institute. He served as the 23rd Commissioner of the U.S. Food and Drug Administration from 2017 to 2019. Prior to serving as Commissioner, Dr. Gottlieb held several roles in the public and private sectors, including serving as the FDA's Deputy Commissioner for Medical and Scientific Affairs and as a Senior Adviser to the Administrator of the Centers for Medicare and Medicaid Services, where he helped implement the Medicare drug benefit, advance policies to improve healthcare quality and promote the effective use of new medical technologies.

  • 30

    Jul

  • 28

    Aug

  • 16

    Sep

PFE Pfizer
$43.43

0.43 (1.00%)

06/21/19
BOFA
06/21/19
NO CHANGE
BOFA
Buy
Sarepta called top small-to-mid cap biotech pick for second half at BofA/Merrill
BofA Merrill Lynch analyst Tazeen Ahmad called Sarepta (SRPT) his top small-to-mid cap biotech pick for the second half of the year, citing several near-term catalysts. Investors have mostly focused on m-dystrophin in Duchenne muscular dystrophy, or DMD, but he believes its pipeline in limb-girdle muscular dystrophy, or LGMD, is not yet fully reflected in the current valuation and thinks catalysts from LGMD will drive upside in the back half of 2019, Ahmad tells investors. Competitor Pfizer (PFE) reports clinical data at PPMD on June 28, which could be a catalyst for Sarepta, as could potential approval of Golodirsen in the U.S. by its August 19 PDUFA date and low dose functional benefit data from the LGMD2E study at WMS in October, said the analyst. He has a Buy rating and $200 price target on Sarepta shares.
06/21/19
PIPR
06/21/19
NO CHANGE
Target $208
PIPR
Overweight
Pfizer data next week meaningful for Sarepta, says Piper Jaffray
Pfizer (PFE) will be presenting initial patient data with its micro-dystrophin Duchenne muscular dystrophy gene therapy at the Parent Project Muscular Dystrophy Conference next week, Piper Jaffray analyst Danielle Brill tells investors in a research note. Given that Pfizer is Sarepta Therapeutics' (SRPT) main competitor, the findings could have meaningful read-through to Sarepta, adds the analyst. She believes any indication that Sarepta may have the superior product "would significantly de-risk the stock." Brill expects Pfizer's data to be a net positive for Sarepta and remains bullish on the shares into the readout with an Overweight rating and $208 price target.
06/18/19
RHCO
06/18/19
DOWNGRADE
Target $48
RHCO
Hold
Array BioPharma downgraded to Hold from Buy at SunTrust
SunTrust analyst Peter Lawson downgraded Array BioPharma (ARRY) to Hold but raised his price target to $48 from $32 after the company announced that it is being acquired by Pfizer (PFE) at that price. The analyst notes that the 79% premium to the company's last closing price looks like a "fair valuation" based on his analysis of past comps and his M&A valuation model. Lawson adds that the the deal is "encouraging" within the biotech space with positive implications for other potential acquisition targets such as Agios Pharmaceuticals (AGIO) and Mirati herapeutics (MRTX) along with companies with strong chemistry such Incyte Corporation (INCY) and Exelixis (EXEL).
06/17/19
JPMS
06/17/19
NO CHANGE
JPMS
Neutral
Array BioPharma 'no bargain' but a clear fit for Pfizer, says JPMorgan
After Pfizer (PFE) announced a $11.4B deal to buy Array BioPharma (ARRY), JPMorgan analyst Christopher Schott said the deal was "no bargain," given that prices for mid-cap biotech are "far from inexpensive," but he sees Array as a logical addition to Pfizer's new launch portfolio. Braftovi/Mektovi, the lead asset for Array, has strong data in melanoma and more recently second and third line metastatic colorectal cancer along with greater than 30 ongoing clinical trials, noted Schott. He expects Pfizer to remain active in looking to complement its internal pipeline with external assets given the "fairly sizable" patent expiration cycle it faces in the mid-to-late 2020s, added the analyst, who keeps a Neutral rating on Pfizer shares.

TODAY'S FREE FLY STORIES

10:02
07/16/19
07/16
10:02
07/16/19
10:02
General news
Housing Market Index data reported »

July Housing Market Index…

10:02
07/16/19
07/16
10:02
07/16/19
10:02
General news
Business Inventories data reported »

May Business Inventories…

GS

Goldman Sachs

$216.98

5.43 (2.57%)

10:01
07/16/19
07/16
10:01
07/16/19
10:01
Hot Stocks
Breaking Hot Stocks news story on Goldman Sachs »

Goldman Sachs says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

DIS

Disney

$144.63

-0.42 (-0.29%)

10:00
07/16/19
07/16
10:00
07/16/19
10:00
Periodicals
ESPN to launch daily morning podcast in October, Washington Post reports »

ESPN is planning to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

COE

China Online Education

$6.84

(0.00%)

10:00
07/16/19
07/16
10:00
07/16/19
10:00
Hot Stocks
China Online Education falls -7.4% »

China Online Education is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRTG

Heritage Insurance

$15.01

-0.94 (-5.89%)

10:00
07/16/19
07/16
10:00
07/16/19
10:00
Hot Stocks
Heritage Insurance falls -5.6% »

Heritage Insurance is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

UGAZ

VelocityShares 3x Long Natural Gas ETN

$16.45

-1.53 (-8.51%)

10:00
07/16/19
07/16
10:00
07/16/19
10:00
Hot Stocks
VelocityShares 3x Long Natural Gas ETN falls -8.6% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTM

Tata Motors

$12.29

0.63 (5.40%)

10:00
07/16/19
07/16
10:00
07/16/19
10:00
Hot Stocks
Tata Motors rises 5.4% »

Tata Motors is up 5.4%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$150.60

11.75 (8.46%)

10:00
07/16/19
07/16
10:00
07/16/19
10:00
Hot Stocks
VelocityShares 3x Inv Natural Gas ETN rises 8.3% »

VelocityShares 3x Inv…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APRN

Blue Apron

$9.09

1.44 (18.82%)

10:00
07/16/19
07/16
10:00
07/16/19
10:00
Hot Stocks
Blue Apron rises 18.8% »

Blue Apron is up 18.8%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

REKR

Rekor Systems

$2.53

0.21 (9.05%)

, NVDA

Nvidia

$165.73

-1.51 (-0.90%)

09:58
07/16/19
07/16
09:58
07/16/19
09:58
Hot Stocks
Rekor Systems reports joining NVIDIA Metropolis Software Partner Program »

Rekor Systems (REKR)…

REKR

Rekor Systems

$2.53

0.21 (9.05%)

NVDA

Nvidia

$165.73

-1.51 (-0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

JBHT

J.B. Hunt

$99.00

6.5 (7.03%)

, R

Ryder

$58.12

1.39 (2.45%)

09:55
07/16/19
07/16
09:55
07/16/19
09:55
Options
Early notable gainers among liquid option names on July 16th »

Notable gainers among…

JBHT

J.B. Hunt

$99.00

6.5 (7.03%)

R

Ryder

$58.12

1.39 (2.45%)

SCHW

Charles Schwab

$41.90

1.62 (4.02%)

FDX

FedEx

$171.00

3.13 (1.86%)

GS

Goldman Sachs

$214.69

3.14 (1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 19

    Jul

  • 30

    Jul

  • 30

    Jul

  • 31

    Jul

  • 26

    Aug

  • 17

    Sep

  • 27

    Oct

  • 13

    Nov

GS

Goldman Sachs

$214.61

3.06 (1.45%)

09:54
07/16/19
07/16
09:54
07/16/19
09:54
Hot Stocks
Breaking Hot Stocks news story on Goldman Sachs »

Goldman Sachs says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

SBUX

Starbucks

$90.02

-0.13 (-0.14%)

09:54
07/16/19
07/16
09:54
07/16/19
09:54
Upgrade
Starbucks rating change at OTR Global »

Starbucks upgraded at OTR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

GS

Goldman Sachs

$213.56

2.01 (0.95%)

, TW

Tradeweb Markets

$47.40

(0.00%)

09:51
07/16/19
07/16
09:51
07/16/19
09:51
Hot Stocks
Breaking Hot Stocks news story on Goldman Sachs, Tradeweb Markets »

Goldman Sachs CFO says…

GS

Goldman Sachs

$213.56

2.01 (0.95%)

TW

Tradeweb Markets

$47.40

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 08

    Aug

09:50
07/16/19
07/16
09:50
07/16/19
09:50
General news
Breaking General news story  »

Atlanta Federal Reserve…

JNJ

Johnson & Johnson

$132.30

-2.37 (-1.76%)

09:49
07/16/19
07/16
09:49
07/16/19
09:49
Hot Stocks
Johnson & Johnson says continues to invest in R&D at 'competitive levels' »

Says: Expects to invest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 09

    Sep

  • 16

    Sep

IMRN

Immuron

$6.62

3.78 (133.10%)

09:48
07/16/19
07/16
09:48
07/16/19
09:48
Hot Stocks
Immuron jumps after reporting FY19 sales of A$2.6M »

Immuron announced earlier…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWLO

Twilio

$146.09

0.735 (0.51%)

09:47
07/16/19
07/16
09:47
07/16/19
09:47
Recommendations
Twilio analyst commentary at JMP Securities »

JMP maintains Outperform…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

SPAR

Spartan Motors

$11.68

1.77 (17.86%)

09:47
07/16/19
07/16
09:47
07/16/19
09:47
Hot Stocks
Spartan Motors receives 2,237-unit walk-in-van order from e-commerce company »

Spartan Fleet Vehicles…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

LEA

Lear

$127.00

-8.08 (-5.98%)

09:47
07/16/19
07/16
09:47
07/16/19
09:47
Hot Stocks
Lear falls -6.3% »

Lear is down -6.3%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

ARW

Arrow Electronics

$64.20

-4.62 (-6.71%)

09:47
07/16/19
07/16
09:47
07/16/19
09:47
Hot Stocks
Arrow Electronics falls -6.6% »

Arrow Electronics is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$16.31

-1.67 (-9.29%)

09:47
07/16/19
07/16
09:47
07/16/19
09:47
Hot Stocks
VelocityShares 3x Long Natural Gas ETN falls -9.3% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTM

Tata Motors

$12.25

0.59 (5.06%)

09:47
07/16/19
07/16
09:47
07/16/19
09:47
Hot Stocks
Tata Motors rises 4.8% »

Tata Motors is up 4.8%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

APRN

Blue Apron

$8.37

0.72 (9.41%)

09:47
07/16/19
07/16
09:47
07/16/19
09:47
Hot Stocks
Blue Apron rises 10.3% »

Blue Apron is up 10.3%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.